Cláudia Bessa Pereira Chaves

4PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersMedical mycologyEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 14, 2025
ESR1 overexpression is a biomarker of relapse and worse prognosis in stage I endometrioid endometrial carcinoma.

C B P Chaves, P Nicolau-Neto, T A Simão

|Jul 07, 2024
Single-cell resolution characterization of myeloid-derived cell states with implication in cancer outcome.

Gabriela Rapozo Guimarães, Giovanna Resk Maklouf, Cristiane Esteves Teixeira

|Oct 17, 2019
Overweight and obesity do not determine worst prognosis in endometrioid endometrial carcinoma.

Gabriela Villaça Chaves, Tatiana de Almeida Simao, Luis Felipe Ribeiro Pinto

|May 18, 2019
Overexpression of HMGA1 Figures as a Potential Prognostic Factor in Endometrioid Endometrial Carcinoma (EEC).

Antonio Palumbo Júnior, Vanessa Paiva Leite de Sousa, Francesco Esposito

Pageof 1